Seizure: European Journal of Epilepsy
Volume 19, Issue 5 , Pages 300-302 , June 2010

Trimetazidine exerts protection against increasing current electroshock seizure test in mice

Received 1 September 2009 ,Revised 27 January 2010 ,Accepted 1 April 2010.

References 

  1. Kulak W, Sobaniec W, Wojtal K, Czuczwar SJ. Calcium modulation in epilepsy. Pol J Pharmacol. 2004;56:29–41
  2. Librowski T, Kubacka M, Meusel M, Scolari S, Muller CE, Gutschow M. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzyhydryl ureides. Eur J Pharmacol. 2007;559:138–149
  3. Gupta YK, Malhotra J. Antiepileptic drug therapy in the twenty first century. Indian J Physiol Pharmacol. 2000;4:8–23
  4. Bading N, Hilmar M. Nuclear calcium-activated gene expression: possible roles in neuronal plasticity and epileptogenesis. Epilepsy Res. 1999;36:225–231
  5. Gupta MC, Garg SK, Das BP, Bhargava VK. Effect of nimodipine, a dihydropyridine calcium channel antagonist on the pharmacokinetics of carbamazepine in rhesus monkey. Indian J Physiol Pharmacol. 2003;47:347–351
  6. Kulak W, Sobaniec W. Anticonvulsant effects of calcium antagonists in the experimental seizures in the rat. Neurosci Jpn. 1993;19:107–112
  7. Albengres E, Tillement JP, Louet HL, Morin D. Trimetazidine: experimental and clinical update review. Cardiovasc Drug Rev. 1998;16:359–390
  8. Harpey C, Clauser P, Labrid C, Freyria JL, Poirier JP. Trimetazidine, a cellular anti-ischemic agent. Cardiovasc Drug Rev. 1989;6:292–312
  9. Iskesen I, Saribulbul O, Cerrahoglu M, Var A, Nazil Y, Sirin H. Trimetazidine reduces oxidative stress in cardiac surgery. Circ J. 2006;70:1169–1173
  10. Belardinelli R. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy. Rev Port Cardiol. 2002;19:35–39
  11. Abdel-Salam OME, El-Batran S. Pharmacological investigation of trimetazidine in models of inflammation, pain and gastric injury in rodents. Pharmacology. 2005;75:122–132
  12. Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF. Energy metabolism in the hypertrophied heart. Heart Fail Rev. 2002;7:161–173
  13. Dhote V, Balaraman R. Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia–reperfusion injury in rats. Clin Exp Pharmacol Physiol. 2008;35:630–637
  14. Iqbal S, Baziany A, Hussain M, James S, Wright S, Hemmings S, et al. Trimetazidine as a potential neuroprotection in transient global ischemia in gerbils: a behavioral and histological study. Brain Res. 2002;928:1–7
  15. Inci I, Dutly A, Rousson V, Bochler A, Weder W. Trimetazidine protects the energy status after ischemia and reduces reperfusion injury in a rat single lung transplant model. J Thorac Cardiovasc Surg. 2001;122:1155–1161
  16. Chander V, Singh D, Chopra K. Attenuation of glycerol-induced acute renal failure in rats by trimetazidine and deferoxamine. Pharmacology. 2003;67:41–48
  17. Tetik C, Ozden A, Calli N, Bilgihan A, Bostanci B, Yis O, et al. Cytoprotective effect of trimetazidine on 60min of intestinal ischemia-reperfusion injury in rats. Transpl Int. 1999;12:108–112
  18. Settaf A, Morin D, Lamchouri F, Elimadi A, Cherrah Y, Tillement JP. Trimetazidine ameliorates the hepatic injury associated with ischemia–reperfusion in rats. Pharmacol Res. 1999;39:211–216
  19. Dayanithi G, Gilles D, Travo C, Chabbert C, Sans A. Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons. Eur J Pharmacol. 2007;574:8–14
  20. Kitano Y, Usui C, Takasuna K, Hirohashi M, Nomura M. Increasing current electroshock seizure test: a new method for assessment of anti-and proconvulsant activities of drugs in mice. J Phamacol Toxicol Methods. 1996;35:25–29
  21. Marwah R, Pal SN, Pillai KK. Effect of fluoxetine on increasing current electro-shock seizures (ICES) in mice. Indian J Pharmacol. 1999;31:350–353
  22. Mironovan OP, Zarubina IV, Krivoruchko BJ, Smirnov AV. Antioxidant effects of amtizol and trimetazidine in brain ischemia. Patol Fiziol Eksp Ter. 2001;7:13–16
  23. Serarslan Y, Bal R, Altug ME, Kontas T, Keles ON, Unal D, et al. Effects of trimetazidine on crush injury of the sciatic nerve in rats: a biochemical and stereological study. Brain Res. 2009;1247:11–20
  24. Suzer T, Coskun E, Demir S, Tahta K. Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: effect of trimetazidine and deferoxamine. Res Exp Med. 2000;199:223–229
  25. Khosla P, Pandhi P. Anticonvulsant effect of nimodipine alone and in combination with diazepam and phenytoin in a mouse model of status epilepticus. Methods Find Exp Clin Pharmacol. 2000;22:731–736
  26. Shitak R, Sahai AK, Hota D, Chakrabarti A. Anti-seizure efficacy of nimodipine in pentylenetetrazole and kainic acid combined seizure models in mice. Indian J Physiol Pharmacol. 2006;50:265–272
  27. Luszczki JJ, Trojnar MK, Trojnar MP, Trojnar ZK, Szostakiewicz B, Zadrozniak A, et al. Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model. Pharmacol Rep. 2007;59:672–682
  28. Czuczwar SJ, Gasior M, Janusz W, Kleinrok Z. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology. 1992;31:1179–1183
  29. Kulak W, Sobaniec W. Effects of cinnarizine, a calcium channel blocker on valproic acid concentration in epileptic children with epilepsy. Neurosci Jpn. 1994;20:187–190
  30. Dolin SJ, Hunter AB, Halsey MJ, Little HJ. Anticonvulsnat profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine. Eur J Pharmacol. 1988;152:19–27
  31. Hocht C, Lazarowski A, Gonzalez NN, Auzmendi J, Opezzo JAW, Bramgulia GF, et al. Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model. Neuroscience Letters. 2007;413:168–172
  32. Kiyosue T, Nakamura S, Arita M. Effects of trimetazidine on action potentials and membrane currents of guinea pig ventricular myocytes. J Mol Cell Cardiol. 1986;18:1301–1311
  33. Astashkin EI, Glezer MG, Grachev SV. Trimetazidine selectively inhibits SOC channels in plasma membranes of human HL-60 cells and does not affect the intracellular Ca2+ stores. Dokl Biol Sci. 2009;424:86–89
  34. Ali A, Pillai KK, Ahmad FJ, Dua Y, Vohora D. Anticonvulsant effect of amiloride in pentetrazole -induced status epilepticus in mice. Pharmacol Rep. 2006;58:242–245
  35. Stefani A, Spadoni F, Bernardi G. Voltage-activated calcium channels, targets of antiepileptic drug therapy?. Epilepsia. 1997;38:959–965
  36. Schumacher TB, Beck H, Steinhaiser C, Schramm J, Elger CE. Effects of phenytoin, carbamazepine and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia. 1998;39:355–363

PII: S1059-1311(10)00072-5

doi: 10.1016/j.seizure.2010.04.001

Seizure: European Journal of Epilepsy
Volume 19, Issue 5 , Pages 300-302 , June 2010

Article Tools